- Drug Price Battle Now Bipartisan; Should Pharma Fret?
- US Capitol Capsule: Barriers to PCSK9s use: What to expect
- French industry kicked off key government committee
- US Capitol Capsule: 'Cures' ain't law yet: Senate concurrence may be tricky
COMMENT Other Informa Comment
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- Profile: Dr Reddy's CEO on mass exits, listening to parents & architecture